EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Escitalopram and brain reactivity to aggressive stimuli in premenstrual dysphoric disorder

Manon Dubol, Maria Gröndal, Felix Schmidt, Patrick M Fisher, Vibe Gedsoe Frokjaer, Johan Wikström, Elias Eriksson iD, Inger Sundstrøm, Erika Comasco iD

The British Journal of Psychiatry · 28.07.2026 · 1-9

DOI: 10.1192/bjp.2026.10721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 28.07.2026. Verfasst von Manon Dubol und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Uppsala University, Sweden. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Premenstrual dysphoric disorder (PMDD) is a condition linked to the menstrual cycle and characterised by cyclic emotional distress, irritability and anger, which can disrupt social functioning. Intermittent selective serotonin reuptake inhibitor treatment is effective in alleviating symptoms, yet the neural underpinnings of its efficacy in PMDD remain unknown.

Aims

This randomised, placebo-controlled trial aimed to evaluate the impact of intermittent escitalopram treatment on PMDD symptoms and aggressiveness, and on neural responses to social provocation.

Method

Women with PMDD were randomised to receive either intermittent escitalopram (20 mg/day) or placebo during the luteal phase. Outcomes of interest were changes in mood (assessed by the Daily Record of Severity of Problems), self-rated state aggression (measured by the Aggression Questionnaire) and neural responses to aggression-related stimuli, captured by functional magnetic resonance imaging during the Point Subtraction Aggression Paradigm.

Results

Intermittent escitalopram treatment significantly reduced PMDD symptoms compared with placebo, in particular irritability or anger (Cohen’s d = −0.93, 95% CI [−1.48, −0.38]). Aggressiveness, which was positively associated with these symptoms (Pearson’s r = 0.33, 95% CI [0.06, 0.55]), diminished following treatment (Cohen’s d = −0.42, 95% CI [1.4 × 10 −4 , 0.84]), with the reduction in irritability or anger partly mediating this association (standardised indirect effect −0.32, 95% CI [−0.77, −0.03]). Escitalopram treatment was nominally associated with lower reactivity to provocation in the anterior insula (involved in salience and threat detection) (Cohen’s d = −0.34, 95% CI [−0.66, −0.02]), the activation of which was positively related to irritability or anger (Spearman’s ρ = 0.39, 95% CI [0.07, 0.64]).

Conclusions

This randomised controlled trial provides timely confirmation of escitalopram as an effective treatment for PMDD within a contemporary clinical context and using prospective daily symptom ratings. Functional neuroimaging suggests that modulation of serotonergic function in PMDD is related to corticolimbic circuits involved in irritability or anger and interpersonal behaviour.

Schlagwörter

Stichwörter der Autor:innen

Premenstrual dysphoric disorderaggressionescitalopramfunctional magnetic resonance imagingselective serotonin uptake inhibitors

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Uppsala University, Sweden.
  • Department of Psychology, University of Gothenburg, Sweden.
  • Department of Drug Design and Pharmacology, University of Copenhagen, Denmark.
  • Neurobiology Research Unit, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark.
  • Psychiatric Center Copenhagen, Mental Health Services in the Capital Region of Denmark, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Denmark.

ORCID-Profile: Elias Eriksson, Erika Comasco

Zitieren

APA

Dubol, M., Gröndal, M., Schmidt, F., Fisher, P. M., Frokjaer, V. G., Wikström, J., Eriksson, E., Sundstrøm, I., & Comasco, E. (2026). Escitalopram and brain reactivity to aggressive stimuli in premenstrual dysphoric disorder. The British Journal of Psychiatry, 1-9. https://doi.org/10.1192/bjp.2026.10721

Vancouver

Dubol M, Gröndal M, Schmidt F, Fisher PM, Frokjaer VG, Wikström J, et al. Escitalopram and brain reactivity to aggressive stimuli in premenstrual dysphoric disorder. The British Journal of Psychiatry. 2026:1-9. doi:10.1192/bjp.2026.10721

BibTeX
@article{Dubol2026,
  author = {Dubol, Manon and Gröndal, Maria and Schmidt, Felix and Fisher, Patrick M and Frokjaer, Vibe Gedsoe and Wikström, Johan and Eriksson, Elias and Sundstrøm, Inger and Comasco, Erika},
  title = {Escitalopram and brain reactivity to aggressive stimuli in premenstrual dysphoric disorder},
  journal = {The British Journal of Psychiatry},
  year = {2026},
  pages = {1--9},
  doi = {10.1192/bjp.2026.10721}
}
Kostenlos starten →